Trinity Biotech PLC
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 91,216 82,510 77,948 89,635
Cost of Revenue 45,996 40,257 37,820 45,690
Gross Profit 45,220 42,253 40,128 43,945
Operating Expenses
Research and Development 3,691 3,130 3,206 4,603
Sales, General and Admin. 32,534 21,957 21,138 25,313
Non-Recurring Items - - - -
Other - - - -
Operating Income 8,995 17,166 15,784 60,503
Income From Continuing Operations
Add'l Income/Expense Items 1,276 2,280 2,428 47,826
Earnings Before Interest and Tax 10,271 19,446 18,212 61,855
Interest Expense 51 88 12 495
Earnings Before Tax 10,220 19,358 18,200 61,360
Income Tax 574 2,017 2,607 942
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 9,646 17,341 15,593 60,418
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 9,646 17,341 15,593 60,418
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 9,646 17,341 15,593 60,418